Skip to main content
SpringerLink
Log in

Protection from Cerebral Embolic Events During Transcatheter Aortic Valve Replacement

  • Interventional Cardiology (S Rao, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Transcatheter aortic valve replacement (TAVR) has been a major advancement in the treatment of high-risk patients with severe aortic stenosis. One of the primary concerns in applying this procedure to a broader patient population is the risk of embolic stroke. Cerebral emboli have been shown to originate from atheromatous plaques within the aorta and from the degenerate stenotic aortic valve itself. Thus, there has been significant interest in embolic protection devices designed to either filter or deflect potential cerebral emboli during TAVR. Here, we review the rationale and current data for embolic protection devices used during TAVR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.

    Article  CAS  PubMed  Google Scholar 

  2. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686–95.

    Article  CAS  PubMed  Google Scholar 

  3. Eggebrecht H, Schmermund A, Voigtländer T, et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012;8:129–38.

    Article  PubMed  Google Scholar 

  4. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–8.

    Article  CAS  PubMed  Google Scholar 

  5. Linke A, Gerckens U, Wenaweser P, et al. Treatment of high risk aortic stenosis patients with transcatheter Medtronic CoreValve implantation: results from the International Multi-Center ADVANCE Study. J Am Coll Cardiol. 2012;59:E8.

    Article  Google Scholar 

  6. Di Mario C, Eltchaninoff H, Moat N, et al. The 2011–12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients. EuroIntervention. 2013;8:1362–71.

    Article  PubMed  Google Scholar 

  7. Fanning JP, Walters DL, Platts DG, et al. Characterization of neurological injury in transcatheter aortic valve implantation: how clear is the picture? Circulation. 2014;129:504–15. Fanning et al. provide a comprehensive review of cerebral vascular events associated with TAVR, the etiology of these events, associated risk factors, and the spectrum of neurological sequelae associated with these events.

    Article  PubMed  Google Scholar 

  8. Holmes DR, Brennan JM, Rumsfeld JS, et al. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA. 2015;313:1019–28.

    Article  CAS  PubMed  Google Scholar 

  9. Knipp SC, Matatko N, Schlamann M, et al. Small ischemic brain lesions after cardiac valve replacement detected by diffusion-weighted magnetic resonance imaging: relation to neurocognitive function. Eur J Cardiothorac Surg Off J Eur Assoc Cardiothorac Surg. 2005;28:88–96.

    Article  Google Scholar 

  10. Omran H, Schmidt H, Hackenbroch M, et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet. 2003;361:1241–6.

    Article  PubMed  Google Scholar 

  11. Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121:870–8.

    Article  PubMed  Google Scholar 

  12. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215–22.

    Article  PubMed  Google Scholar 

  13. Bijuklic K, Wandler A, Tübler T, Schofer J. Impact of asymptomatic cerebral lesions in diffusion-weighted magnetic resonance imaging after carotid artery stenting. JACC Cardiovasc Interv. 2013;6:394–8.

    Article  PubMed  Google Scholar 

  14. Ghanem A, Kocurek J, Sinning JM, et al. Cognitive trajectory after transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2013;6:615–24.

    Article  PubMed  Google Scholar 

  15. Mastoris I, Schoos MM, Dangas GD, Mehran R. Stroke after transcatheter aortic valve replacement: incidence, risk factors, prognosis, and preventive strategies. Clin Cardiol. 2014;37:756–64.

    Article  PubMed  Google Scholar 

  16. Van Mieghem NM, Faquir El N, Rahhab Z, et al. Incidence and predictors of debris embolizing to the brain during transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2015;8:718–24. This study is important because it increases our understanding of the etiology of cerebrovascular emboli, as well as patient and procedural risk factors associated with increased embolic events during TAVR.

    Article  PubMed  Google Scholar 

  17. Hamon M, Baron J-C, Viader F, Hamon M. Periprocedural stroke and cardiac catheterization. Circulation. 2008;118:678–83.

    Article  PubMed  Google Scholar 

  18. Rodés-Cabau J, Dumont E, Boone RH, et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57:18–28.

    Article  PubMed  Google Scholar 

  19. Mohler ER, Adam LP, McClelland P, et al. Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol. 1997;17:547–52.

    Article  PubMed  Google Scholar 

  20. Mohler ER, Gannon F, Reynolds C, et al. Bone formation and inflammation in cardiac valves. Circulation. 2001;103:1522–8.

    Article  PubMed  Google Scholar 

  21. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005;111:3316–26.

    Article  PubMed  Google Scholar 

  22. Fairbairn TA, Mather AN, Bijsterveld P, et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart. 2012;98:18–23.

    Article  PubMed  Google Scholar 

  23. Nombela-Franco L, Rodés-Cabau J, DeLarochellière R, et al. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2012;5:499–512.

    Article  PubMed  Google Scholar 

  24. Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. 2014;311:1503–14.

    Article  PubMed  Google Scholar 

  25. Grube E, Naber C, Abizaid A, et al. Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study. JACC Cardiovasc Interv. 2011;4:751–7.

    Article  PubMed  Google Scholar 

  26. Kahlert P, Al-Rashid F, Döttger P, et al. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation. 2012;126:1245–55.

    Article  PubMed  Google Scholar 

  27. Naber CK, Ghanem A, Abizaid AA, et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2012;8:43–50.

    Article  PubMed  Google Scholar 

  28. Rodés-Cabau J, Kahlert P, Neumann F-J, et al. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study. JACC Cardiovasc Interv. 2014;7:1146–55.

    Article  PubMed  Google Scholar 

  29. Samim M, Agostoni P, Hendrikse J, et al. Embrella embolic deflection device for cerebral protection during transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2015;149:799–805.e1–2.

    Article  PubMed  Google Scholar 

  30. Lansky AJ, Schofer J, Tchetche D, et al. A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J. 2015;36:2070–8.

    Article  PubMed  Google Scholar 

  31. Ye J, Webb JG. Embolic capture with updated intra-aortic filter during coronary artery bypass grafting and transaortic transcatheter aortic valve implantation: first-in-human experience. J Thorac Cardiovasc Surg. 2014;148:2905–10.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Washington, 1959 NE Pacific St, Box 356421, Seattle, WA, 98195, USA

    Charles F. Rossow

  2. University of Washington, 1959 NE Pacific St, Box 356422, Seattle, WA, 98195, USA

    James M. McCabe

Authors
  1. Charles F. Rossow
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James M. McCabe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James M. McCabe.

Ethics declarations

Conflict of Interest

Charles F. Rossow and James M. McCabe declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Interventional Cardiology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rossow, C.F., McCabe, J.M. Protection from Cerebral Embolic Events During Transcatheter Aortic Valve Replacement. Curr Cardiol Rep 18, 16 (2016). https://doi.org/10.1007/s11886-015-0692-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-015-0692-7

Keywords

Search

Navigation